In addition, you must meet one of the three clinical criteria set by CMS, measured at the time you start GLP-1 therapy: BMI of 35 or higher (and age 18 or older), or BMI of 30 or higher (and age 18 or older), plus one of the following: heart failure with preserved ejection fraction, uncontrolled high blood pressure (systolic above 140 or diastolic above 90 despite treatment with two blood pressure medications), or chronic kidney disease stage 3a or above, or BMI of 27 or higher (and age 18 or older), plus one of the following: prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease If you take a GLP-1 for another condition, the Bridge is not for you
Its legal status reflects the absence of completed clinical trials rather than a safety determination
Unlike oral B-vitamin supplements, which must pass through the digestive system, B-Complex IM and IV therapy provide direct delivery for better absorption and faster results
Companies such as Novo Nordisk and Eli Lilly have sent cease-and-desist letters to parties involved in the manufacture, sale, and distribution of unauthorized GLP-1 products
3.If the odor remains severe, would a short course of an oral antibiotic be appropriate to temporarily reset the gut bacteria